The HAI-IDR has focused on two yet unsolved challenges posed by viral hepatitis, therapeutic vaccines against HBV and prophylactic vaccines against HCV. With a view to the future expansion into other infectious diseases, moreover, the focus has been on developing platforms and technologies that can later on be applied to other infectious diseases as well. These common platforms and technologies include:

  • Tailoring viral interactions with antigen presenting cells
  • Tailoring vaccine adjuvants
  • Tailoring vaccine vectors
  • Analysis of anti-viral immunity

Therapeutic HBV vaccines

Research Partners: